Cargando…
Characterization of APOE Christchurch carriers in 455,306 UK Biobank participants
Autores principales: | He, Karen Y., Khramtsova, Ekaterina A., Cabrera-Socorro, Alfredo, Zhang, Yanfei, Li, Shuwei, Sarver, Brice A. J., Smets, Bart, Li, Qingqin S., De Muynck, Louis, Parrado, Antonio R., Lovestone, Simon, Black, Mary Helen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10685495/ https://www.ncbi.nlm.nih.gov/pubmed/38017580 http://dx.doi.org/10.1186/s13024-023-00684-7 |
Ejemplares similares
-
Resistance to autosomal dominant Alzheimer’s in an APOE3-Christchurch homozygote: a case report
por: Arboleda-Velasquez, Joseph F., et al.
Publicado: (2019) -
Gliovascular alterations in sporadic and familial Alzheimer's disease:
APOE3
Christchurch homozygote glioprotection
por: Henao‐Restrepo, Julián, et al.
Publicado: (2022) -
Distinct tau neuropathology and cellular profiles of an APOE3 Christchurch homozygote protected against autosomal dominant Alzheimer’s dementia
por: Sepulveda-Falla, Diego, et al.
Publicado: (2022) -
Testosterone and socioeconomic position: Mendelian randomization in 306,248 men and women in UK Biobank
por: Harrison, Sean, et al.
Publicado: (2021) -
Christchurch shallow groundwater quality survey dataset
por: Setiawan, Irene, et al.
Publicado: (2022)